BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21911833)

  • 1. Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking.
    Mayol K; Biajoux V; Marvel J; Balabanian K; Walzer T
    Blood; 2011 Nov; 118(18):4863-71. PubMed ID: 21911833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow.
    Jenne CN; Enders A; Rivera R; Watson SR; Bankovich AJ; Pereira JP; Xu Y; Roots CM; Beilke JN; Banerjee A; Reiner SL; Miller SA; Weinmann AS; Goodnow CC; Lanier LL; Cyster JG; Chun J
    J Exp Med; 2009 Oct; 206(11):2469-81. PubMed ID: 19808259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor.
    Walzer T; Chiossone L; Chaix J; Calver A; Carozzo C; Garrigue-Antar L; Jacques Y; Baratin M; Tomasello E; Vivier E
    Nat Immunol; 2007 Dec; 8(12):1337-44. PubMed ID: 17965716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response.
    Fang V; Chaluvadi VS; Ramos-Perez WD; Mendoza A; Baeyens A; Rivera R; Chun J; Cammer M; Schwab SR
    Nat Immunol; 2017 Jan; 18(1):15-25. PubMed ID: 27841869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets.
    Bernardini G; Sciumè G; Bosisio D; Morrone S; Sozzani S; Santoni A
    Blood; 2008 Apr; 111(7):3626-34. PubMed ID: 18227348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4
    Levy E; Reger R; Segerberg F; Lambert M; Leijonhufvud C; Baumer Y; Carlsten M; Childs R
    Front Immunol; 2019; 10():1262. PubMed ID: 31231387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CX3CR1 expression defines 2 KLRG1+ mouse NK-cell subsets with distinct functional properties and positioning in the bone marrow.
    Sciumè G; De Angelis G; Benigni G; Ponzetta A; Morrone S; Santoni A; Bernardini G
    Blood; 2011 Apr; 117(17):4467-75. PubMed ID: 21364193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice.
    Beider K; Nagler A; Wald O; Franitza S; Dagan-Berger M; Wald H; Giladi H; Brocke S; Hanna J; Mandelboim O; Darash-Yahana M; Galun E; Peled A
    Blood; 2003 Sep; 102(6):1951-8. PubMed ID: 12730102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization.
    Biajoux V; Natt J; Freitas C; Alouche N; Sacquin A; Hemon P; Gaudin F; Fazilleau N; Espéli M; Balabanian K
    Cell Rep; 2016 Sep; 17(1):193-205. PubMed ID: 27681431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow.
    Bernardini G; Sciumè G; Santoni A
    Front Immunol; 2013; 4():12. PubMed ID: 23386850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CX3CR1 regulates the maintenance of KLRG1+ NK cells into the bone marrow by promoting their entry into circulation.
    Ponzetta A; Sciumè G; Benigni G; Antonangeli F; Morrone S; Santoni A; Bernardini G
    J Immunol; 2013 Dec; 191(11):5684-94. PubMed ID: 24184559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Homeostasis of natural killer cells].
    Rouzaire P; Mayol K; Viel S; Bienvenu J; Walzer T
    Med Sci (Paris); 2012 Apr; 28(4):403-8. PubMed ID: 22549868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice.
    Balabanian K; Brotin E; Biajoux V; Bouchet-Delbos L; Lainey E; Fenneteau O; Bonnet D; Fiette L; Emilie D; Bachelerie F
    Blood; 2012 Jun; 119(24):5722-30. PubMed ID: 22438253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
    Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
    Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
    Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism.
    Kabashima K; Haynes NM; Xu Y; Nutt SL; Allende ML; Proia RL; Cyster JG
    J Exp Med; 2006 Nov; 203(12):2683-90. PubMed ID: 17101733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation.
    Gallego C; Vétillard M; Calmette J; Roriz M; Marin-Esteban V; Evrard M; Aknin ML; Pionnier N; Lefrançois M; Mercier-Nomé F; Bertrand Y; Suarez F; Donadieu J; Ng LG; Balabanian K; Bachelerie F; Schlecht-Louf G
    Blood; 2021 May; 137(20):2770-2784. PubMed ID: 33512478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.
    Jaillard C; Harrison S; Stankoff B; Aigrot MS; Calver AR; Duddy G; Walsh FS; Pangalos MN; Arimura N; Kaibuchi K; Zalc B; Lubetzki C
    J Neurosci; 2005 Feb; 25(6):1459-69. PubMed ID: 15703400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.
    Yang J; Kumar A; Vilgelm AE; Chen SC; Ayers GD; Novitskiy SV; Joyce S; Richmond A
    Cancer Immunol Res; 2018 Oct; 6(10):1186-1198. PubMed ID: 30108045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.